Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ABTS | Abits Group | $4.57 | $2.57 | 128.49% | 21.2M | $4.7M | $1.35$10.86 |
| TNDM | Tandem Diabetes Care | $25.66 | $7.14 | 38.53% | 193.8K | $1.3B | $9.98$35.12 |
| HTLM | HomesToLife | $2.53 | $0.70 | 38.25% | 17.1M | $164M | $1.80$4.82 |
| RNG | RingCentral | $39.55 | $10.16 | 34.56% | 8.7M | $2.5B | $20.59$40.64 |
| FNKO | Funko | $5.52 | $1.10 | 24.89% | 4.7M | $242M | $2.22$14.15 |
| JAKK | JAKKS Pacific | $22.38 | $4.22 | 23.24% | 546.4K | $205M | $14.87$30.50 |
| AXTI | AXT | $29.27 | $5.46 | 22.93% | 650.1K | $1.3B | $1.13$30.68 |
| NCI | Neo-Concept International Group | $5.49 | $1.00 | 22.27% | 3.3M | $18M | $0.72$7.68 |
| RMNI | Rimini Street | $3.60 | $0.63 | 21.06% | 1.1M | $273M | $2.79$5.38 |
| TROO | Troops | $3.87 | $0.67 | 20.78% | 769.5K | $346M | $0.49$5.28 |
| KOS | Kosmos Energy | $2.13 | $0.36 | 20.59% | 29.7M | $847M | $0.84$3.36 |
| ANGH | Anghami | $2.85 | $0.49 | 20.55% | 5.7K | $16M | $2.25$7.60 |
| FOXX | Foxx Development | $5.20 | $0.88 | 20.37% | 18.5K | $30M | $1.71$8.88 |
| ASIC | Ategrity Specialty Insurance | $20.95 | $3.45 | 19.71% | 462.8K | $841M | $16.35$25.30 |
| NTHI | NeOnc Technologies | $10.28 | $1.68 | 19.54% | 28.7K | $195M | $3.20$25.00 |
| STI | Solidion Technology | $3.82 | $0.62 | 19.22% | 214.1K | $25M | $2.94$33.99 |
| SNSE | Sensei Biotherapeutics | $32.43 | $5.21 | 19.14% | 331.8K | $34M | $5.00$33.99 |
| INSG | Inseego | $12.48 | $1.92 | 18.18% | 27.7K | $162M | $6.24$18.11 |
| CDIO | Cardio Diagnostics | $2.60 | $0.36 | 16.07% | 62.6M | $4.1M | $0.97$17.39 |
| NVNO | enVVeno Medical | $11.56 | $1.57 | 15.72% | 728 | $5.8M | $8.67$196.70 |
| LGN | Legence | $54.61 | $7.33 | 15.50% | 1.2M | $5.0B | $26.96$54.99 |
| TLX | Telix Pharmaceuticals | $7.70 | $0.99 | 14.75% | 7.2K | $2.3B | $6.28$30.36 |
| FIVN | Five9 | $19.59 | $2.41 | 14.03% | 214.1K | $1.3B | $15.70$49.90 |
| OIS | Oil States International | $11.40 | $1.40 | 14.00% | 38.5K | $597M | $3.08$11.49 |
| RBOT | Vicarious Surgical | $2.09 | $0.25 | 13.31% | 112.8K | $13M | $1.71$14.63 |
| SATL | Satellogic | $3.67 | $0.41 | 12.58% | 8.8M | $466M | $1.26$5.93 |
| INDP | Indaptus Therapeutics | $2.04 | $0.20 | 10.87% | 18K | $4.1M | $1.52$47.60 |
| TLSI | TriSalus Life Sciences | $5.11 | $0.50 | 10.85% | 463.6K | $230M | $3.42$7.95 |
Related Articles
Featured Article
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
Think Five9 Stock Is Expensive? This Chart Might Change Your Mind.
Anders Bylund|Aug 28, 2025
Is Five9's lofty valuation scaring you off? Maybe you're looking at the wrong metrics. This simple chart might change your perspective.
3 Top Bargain Stocks Ready for a Bull Run
Leo Sun|Jun 5, 2025
Five9, Dell, and Innodata could head higher in the near future.
2 Beaten-Down Stocks That Are Worth Buying
Prosper Junior Bakiny|Feb 4, 2024
Don't be too quick to ignore these stocks.
2 Stocks Under $25 to Buy and Hold for 10 Years
Prosper Junior Bakiny|Sep 29, 2023
There's no need to break the bank to get in on the action.
This Stock Could Soar By as Much as 106%, According to Wall Street
Prosper Junior Bakiny|Mar 5, 2023
Some of Wall Street's predictions seem a bit aggressive, but investors should still consider this company.
2 Growth Stocks to Buy While They Are Still Down
Prosper Junior Bakiny|Jan 27, 2023
Don't wait too long before loading up on these stocks.
2 Stocks Down 72% or More to Buy in 2023 and Hold for 10 Years
Prosper Junior Bakiny|Dec 24, 2022
These companies' shareholders will have the last laugh.
Buy These 2 Beaten-Growth Stocks Before They Soar
Prosper Junior Bakiny|Nov 11, 2022
You'll thank me down the road.
Is Funko Stock a Buy After Its 60% Selloff?
Rich Smith|Nov 10, 2022
Funko stock sells for a seemingly cheap P/E ratio, but beware of falling profit margins.
